Live Breaking News & Updates on Chow Sin

Stay updated with breaking news from Chow sin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Leprosy drug holds promise as at-home treatment for COVID-19


 E-Mail
IMAGE: Sumit Chanda, co-senior study author and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys.
view more 
Credit: Sanford Burnham Prebys Medical Discovery Institute
LA JOLLA, CALIF. - March 16, 2021 - A
Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization s List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2 and prevents the exaggerated inflammatory response associated with severe COVID-19. Based on these findings, a Phase 2 study evaluating clofazimine as an at-home treatment for COVID-19 could begin immediately. ....

Hong Kong , University Of California Los Angeles , United States , Yuan Zhang , Chow Sin , Yuan Pu , University Of Hong Kong , Hong Kong General , Kan Tong , Dong Wang , Los Angeles , University Of California San Diego , Jeffreyd Esko , Dinah Ruch , Runming Wang , Honglin Chen , Kwok Yung Yuen , Laura Riva , Yiu Lee , Chris Chung , Tse Kam Ming , Xue Hui Cai , Ronghui Liang , Carol Yu , Anna Jinxia Zhang , Jasper Fuk ,